Contrast sensitivity in obese dyslipidemic patients with insulin resistance

Archives of Ophthalmology

Volumn 116, Issue 10, 1998, Pages 1316-1320

  Dosso, André A ^a   Yenice Ustun, Ferah ^a   Sommerhalder, Jorg ^a   Golay, Alain ^a   Morel, Yves ^a   Leuenberger, Peter M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PHOTOPIC VISION; PRIORITY JOURNAL; VISUAL ACUITY;

EID: 0031714814     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.10.1316     Document Type: Article

References (30)

1. Della Sala S, Bertoni G, Somazzi L, Stubbe F, Wilkins AJ. Impaired contrast sensitivity in diabetic patients with or without retinopathy: a new technique for rapid assessment. Br J Ophthalmol. 1985;69:136-142.
2. Sokol S, Moskowitz A, Skarf B, Evans E, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985;103:51-54.
3. Ghafour IM, Foulds WS, Allan D, McClure E. Contrast sensitivity in diabetic subjects with or without retinopathy. Br J Ophthalmol. 1982;66:492-495.
4. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1988;95:693-698.
5. Di Leo MAS, Caputo S, Falsini B, et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care. 1992;15:620-625.
6. Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 1996;234:300-305.
7. Harris A, Arend O, Danis RP, Evans E, Wolf S, Martin BJ. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol. 1996;80:209-213.
8. Brinchmann-Hansen O, Bangstad HJ, Hultgren S, et al. Psychophysical visual function, nephropathy, and glycemic control in insulin-dependent diabetics with normal visual acuity. Acta Ophthalmol (Copenh). 1993;71:230-237.
9. Aspinall PA, Kinnear PR, Duncan LJP, Clarke BF. Prediction of diabetic retinopathy from clinical variables and color vision data. Diabetes Care. 1983;6:144-148.
10. Roy MS, Gunkel RD, Podgor MJ. Color vision detects in early diabetic retinopathy. Arch Ophthalmol. 1986;104:225-228.
11. Hardy KJ, Lipton J, Foster DH, Scarpello JHB. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol. 1992;76:461-464.
12. Hardy KJ, Scarpello JHB, Foster DH, Moreland JD. Effect of diabetes associated increases in lens optical density on colour discrimination in insulin dependent diabetes. Br J Ophthalmol. 1994;78:754-756.
13. Arden GB, Hamilton AMP, Wilson-Hoyt J, Ryan S, Yudkin JS, Kurtz A. Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test. Br J Ophthalmol. 1986;70:330-335.
14. Puvanendran K, Devathasan G, Wong PK. Visual evoked responses in diabetes. J Neurol Neurosurg Psychiatry. 1983;46:643-647.
15. Di Leo MAS, Falsini B, Caputo S, Ghirlanda G, Porciatti V, Greco AV. Spatial frequency-selective losses with pattern electroretinogram in type I diabetic patients without retinopathy. Diabetologia. 1990;33:726-730.
16. Sloan LL. New test charts for the measurements of visual acuity at far and near distances. Am J Ophthalmol. 1959;48:807-812.
17. De Natale R, Flammer J, Zulauf M, Bebie T. Influence of age on the transparency of the lens in normals: a population study with the help of the Lens Opacity Meter 701. Ophthalmologica. 1988;197:14-18.
18. Nagulesparan M, Savage PJ, Unger RH, Bennett PH. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes. 1979;28:980-983.
19. Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intraarterial insulin: characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest. 1962;41:2173-2179.
20. Golay A, Chen Y-DI, Reaven GM. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab. 1986;62:1081-1088.
21. Randle PJ, Garland PB, Hales CN. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
22. Golay A, Felber JP, Jallut D, Munger R, Ruiz J, Jéquier E. Effect of lipid oxidation on the regulation of glucose utilization in obese patients. Acta Diabetol. 1995;32:44-48.
23. Golay A, Felber JP. Evolution from obesity to diabetes. Diabetes Metab. 1994;20:3-14.
24. Morel Y, Gadient A, Keller U, Vadas L, Golay A. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol. J Cardiovasc Pharmacol. 1995;26:306-311.
25. Karadeniz S, Kir N, Yilmaz MT, et al. Alteration of visual function in impaired glucose tolerance. Eur J Ophthalmol. 1996;6:59-62.
26. Chylack LT Jr, Padhye N, Khu PM, et al. Loss of contrast sensitivity in diabetic patients with LOGS II classified cataracts. Br J Ophthalmol. 1993;77:7-11.
27. Maraini G, Rosmini F, Graziosi P, et al, and the Italian American Cataract Study Group. Influence of type and severity of pure forms of age-related cataract on visual acuity and contrast sensitivity. Invest Ophthalmol Vis Sci. 1994;35:262-267.
28. Bosc JM, Delbosc B, Blum D, Bron A, Rover S. Présentation d'un apparell de mesure de l'opacité cristallinienne: L'Opacity Lensmeter 701. Bull Soc Ophtalmol. 1988;12:1387-1392.
29. Harrad RA, Cockram CS, Plumb AP, Stone S, Fenwick P, Sonksen PH. The effect of hypoglycemia on visual function: a clinical and electrophysiological study. Clin Sci (Colch). 1985;69:673-679.
30. Klein R, Klein BEK, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15:1875-1891.